Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction
Condition(s) studied
Study summary
A low plasma level of mannose binding lectin (p-MBL) is associated with unexplained recurrent pregnancy loss (RPL), but it is not investigated if it is associated with unexplained reproductive failure in general, including recurrent implantation failure (RIF) after assisted reproductive technology (ART) (including IVF, ICSI and FET), recurrent pregnancy loss (RPL) after spontaneous conception, and RPL after ART.
Eligibility
Primary outcome measure(s)
- Low p-MBL level — Blood sample collected after admission when the patient is not pregnant or <9 weeks of gestation.
Low plasma mannose binding lectin level defined as \<500 ug/l - Very low p-MBL level — Blood sample collected after admission when the patient is not pregnant or <9 weeks of gestation.
Very low plasma mannose binding lectin level defined as \<100 ug/l - High p-MBL level — Blood sample collected after admission when the patient is not pregnant or <9 weeks of gestation.
High plasma mannose binding lectin level defined as \>3000 ug/l
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Aagaard Klinik | Aarhus | Denmark | Recruiting |
More Aalborg University Hospital trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05169541 on ClinicalTrials.gov ↗ ← All trials in Denmark